BMC Psychiatry Volume 4
|
Viewing options:Associated material:Related literature:- Articles citing this article
- Other articles by authors
- Related articles/pages
Tools:Post to:
|
 Research articleThe link between thyroid autoimmunity (antithyroid peroxidase autoantibodies) with anxiety and mood disorders in the community: a field of interest for public health in the futureMauro Giovanni Carta1 , Andrea Loviselli2 , Maria Carolina Hardoy1,3 , Sergio Massa1 , Mariangela Cadeddu1 , Claudia Sardu4 , Bernardo Carpiniello1 , Liliana Dell'Osso3 and Stefano Mariotti2  1Department of Public Health, Division of Psychiatry, University of Cagliari, Italy 2Department of Internal Medicine, University of Cagliari, Italy 3Department of Psychiatry, Neurobiology, Pharmacology, Biotechnology, University of Pisa, Italy 4Department of Public Health, University of Cagliari, Italy author email corresponding author email
BMC Psychiatry 2004,
4:25doi:10.1186/1471-244X-4-25
|
|
| Published: |
18 August 2004 |
Abstract
Background
To evaluate the association between mood and anxiety disorders and thyroid autoimmunity in a community sample. Methods: A community based sample of 222 subjects was examined. Psychiatric diagnoses were formulated using the International Composite Diagnostic Interview Simplified (CIDIS), according to DSM-IV criteria. All subjects underwent a complete thyroid evaluation including physical examination, thyroid echography and measure of serum free T4 (FT4), free T3 (FT3), thyroid-stimulating hormone (TSH) and anti-thyroid peroxidase autoantibodies (anti-TPO).
Results
16.6% of the overall sample had an anti-TPO value above the normal cut-off. Subjects with at least one diagnosis of anxiety disorders (OR = 4.2, C.L. 95% 1.9–38.8) or mood disorders (OR = 2.9, Cl 95% 1.4–6.6, P < 0.011) were positive for serum anti-TPO more frequently than subjects without mood or anxiety disorders. A statistically significant association with anti-TPO+ was found in Anxiety Disorder Not Otherwise Specified (OR = 4.0, CL 95% 1.1–15.5), in Major Depressive Episode (OR = 2.7, CL 95% 1.1–6.7) and Depressive Disorder Not Otherwise Specified (OR = 4.4, S CL 95% 1–19.3).
Conclusions
The study seems to suggest that individuals in the community with thyroid autoimmunity may be at high risk for mood and anxiety disorders. The psychiatric disorders and the autoimmune reaction seem to be rooted in a same (and not easy correctable) aberrancy in the immuno-endocrine system. Should our results be confirmed, the findings may be of great interest for future preventive and case finding projects. |